NFKB1 and Alzheimer disease: NF-κB is considered as the master regulator of the pro-inflammatory programs activated by a plethora of triggers including cellular senescence (Hernandez-Segura et al., 2018), and its signaling has been extensively implicated in the development of the major ARDs, including AD (Jones and Kounatidis, 2017).